Get all your news in one place.

100's of premium titles.
One app.

Start reading

Get all your news in one place.

100's of premium titles. One news app.

Start reading

The Latest Breaking News from Clinical Trial

Clinical Trials Show Moderna's New mRNA Flu Vaccine Is Safe and Effective. FDA Won't Even Consider It.

An overzealous government agency suppresses medical innovation yet again.

Reason

Sanofi CEO: The enterprise AI shift will reshape pharma in 2026

At Sanofi, AI has shifted from experimentation to becoming a vital part of our infrastructure.

Fortune

Wes Streeting ‘not comfortable’ with puberty blocker clinical trial

The Health Secretary made a ban on puberty blockers indefinite in December last year.

Evening Standard

From analysis to the latest developments in health,
read the most diverse news in one place.

Innovative therapy gives hope to patients whose blood cancer ‘seemed incurable’

Almost two thirds of patients with T-cell acute lymphoblastic leukaemia involved in a clinical trial of the treatment are now disease-free.

Evening Standard

Kymera Stock Smashes 52-Week High As New Pill Crushes Eczema Markers

Kymera Therapeutics, Inc. (NASDAQ:KYMR) on Monday released clinical results from the BroADen Phase 1b atopic dermatitis (AD) clinical trial of KT-621, its oral STAT6 degrader medicine.

Benzinga

What's Up With The Jump In Viking Therapeutics Stock?

Viking Therapeutics Inc (NASDAQ:VKTX) shares are trading higher on Thursday. The clinical-stage biopharmaceutical company seems to be benefitting from wider excitement in the obesity treatment area, as well as recent positive momentum after major clinical trial developments.

Benzinga

‘Next generation’ treatment to cure leukaemia given NHS approval

‘The biggest thing it offers is hope,’ says patient involved in clinical trial which cured cancer in significant portion of leukaemia sufferers

The Independent UK

Read news from The Economist, FT, and more,
with one subscription

Two UK clinical trials to assess impact of puberty blockers in young people

Multi-year studies announced after Cass review found ‘insufficient evidence’ about effects on children with gender dysphoria

The Guardian - UK

NIH cuts impacted 74,000 clinical trial patients: study

The termination of federal research grants disrupted about 1 in 30 NIH-funded clinical trials.

Axios

Moderna Q3 2025 Earnings Call Transcript

Moderna, Inc (NASDAQ:MRNA) reported third-quarter financial results on Thursday. The transcript from the company’s third-quarter earnings call has been provided below. MRNA is building positive momentum. Watch the momentum here This transcript is brought to you by Benzinga APIs. For real-time access to our entire catalog, please visithttps://www.benzinga.com/apis/for a consultation. Operator…

Benzinga

First clinical trial testing pig kidney transplants in people launches in US

The small trial is the latest step in the quest for animal-to-human transplants.

Euronews

World’s first gene-edited pig kidney transplants begin in clinical trial

IN FULL

The Independent UK

Groundbreaking pig organ transplant trial gets underway

It’s the latest step in the quest for animal-to-human transplants

The Independent UK

In drug trials, lack of oversight of research ethics boards could put Canadian patients at risk

New drug approvals by Health Canada are based on the results of clinical trials. But before clinical trials can go ahead, they need to be approved by ethics committees known as Research Ethics Boards (REBs).

The Conversation

Get all your
news in one place.

100's of premium titles.
One news app.

The Independent UK

Teacher becomes first UK patient to receive ‘gamechanger’ therapy for MS

Emily Henders received her CAR T last week at University College London Hospital (UCLH) as part of a global clinical trial

The Independent UK

Woman who lost vision can read again after ‘life-changing’ clinical trial

Sheila Irvine was one of 38 patients to be included in the world-first study

Evening Standard

‘Avid bookworm’ who lost vision ‘optimistic’ after implant helps her read again

Sheila Irvine, from Wiltshire, was one of the UK patients included in a groundbreaking clinical trial.

The Independent UK

Brain cancer patients left ‘devastated’ as new drug is rejected for NHS use

Patients who have taken the drug in clinical trials report remarkable results, including their tumours shrinking

Get all your
news in one place.

100's of premium titles.
One news app.

Evening Standard

Patients with brain cancer express disappointment after drug rejected for NHS

Patients who have taken the drug in clinical trials report remarkable results, including their tumours shrinking.

Benzinga

Pfizer Seeks Expanded Use Approval For Breast Cancer Drug

Pfizer Inc. (NYSE:PFE) on Tuesday announced the initial results from a clinical trial called HER2CLIMB-05.

The Independent UK

Company backed by Sam Altman gets FDA approval to trial ‘legal ecstasy’

Clinical trials of ‘safer MDMA’ could lead to new way of treating mental health problems, biotech firm says

Benzinga

EXCLUSIVE: Envoy Medical Cuts Capital Needs After FDA Approval For Final Trial Stage Of Cochlear Implant Trial

Envoy Medical Inc. (NASDAQ:COCH) announced on Tuesday that it has received U.S. Food and Drug Administration (FDA) approval to expand its pivotal clinical trial for the fully implanted Acclaim cochlear implant to the final stage, based on promising three-month data from the first 10 patients.

Benzinga

Harmony Biosciences' Genetic Disorder Drug Disappoints In Phase 3 Study

Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY) released topline results from its Phase 3 registrational clinical trial (the RECONNECT Study) of ZYN002 in Fragile X syndrome (FXS).

The Conversation

Some new drugs aren’t actually ‘new’ – pharmaceutical companies exploit patents and raise prices for patients, but data transparency can help protect innovation

Pharmaceutical innovation saves lives. But not every “new” drug is truly new.

Benzinga

Why MBX Biosciences Shares Are Trading Higher By 28%; Here Are 20 Stocks Moving Premarket

Shares of MBX Biosciences, Inc. (NASDAQ:MBX) rose sharply in pre-market trading after the company announced that it will provide topline results from its Phase 2 clinical trial of potential once-weekly canvuparatide for patients with chronic hypoparathyroidism on Sep. 22.

1 2 3 4 5

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Great Ormond Street Hospital

94 stories

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.